THERAPEUTIC CONJUGATE CONSISTING OF A MEK INHIBITOR AND A TARGETING AGENT

Details for Australian Patent Application No. 2003240080 (hide)

Owner CAMBRIDGE BIOTECHNOLOGY LTD

Inventors LEE, Kevin; HO, Michael, Ting, Bong

Pub. Number AU-A-2003240080

PCT Number PCT/GB03/02501

PCT Pub. Number WO2003/103717

Priority 0213383.3 11.06.02 GB

Filing date 11 June 2003

Wipo publication date 22 December 2003

International Classifications

A61K 047/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 047/46 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Ingredients of undetermined constitution or reaction products thereof

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 0213383.3 11.06.02 GB

19 February 2004 Application Open to Public Inspection

  Published as AU-A-2003240080

3 March 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003240081-Contraceptive sheath with integrated bead construction

2003240079-Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions